# Access Protocol for MAB-425 Radiolabeled With I-125 for High Grade Gliomas

> **NCT01317888** · NA · UNKNOWN · sponsor: **Drexel University** · enrollment: 11 (estimated)

## Conditions studied

- Glioblastoma Multiforme
- Astrocytoma Anaplastic Foci

## Interventions

- **DRUG:** MAB-425 radiolabeled with I-125

## Key facts

- **NCT ID:** NCT01317888
- **Lead sponsor:** Drexel University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-01
- **Primary completion:** 2014-01
- **Final completion:** —
- **Target enrollment:** 11 (ESTIMATED)
- **Last updated:** 2011-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01317888

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01317888, "Access Protocol for MAB-425 Radiolabeled With I-125 for High Grade Gliomas". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01317888. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*